MedTrace Logo

Expressive Writing for COVID-19 Resilience

NCT04589104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2020-10-19

No results posted yet for this study

Summary

The purpose of this study is to determine the impact of a 6-week, virtually-delivered expressive writing intervention on resilience in a cohort of individuals currently navigating the COVID-19 pandemic during spring 2020.

Conditions

  • Distress Due to COVID-19

Interventions

BEHAVIORAL

Expressive writing

The expressive writing intervention consists of a 6-week, virtually-delivered writing program. Each week, participants meet for 90 minutes via Zoom and will be guided through writing prompts designed to encourage emotional expression and enhance personal resilience. The progression of writing exercises flows as follows: * Week 1: Writing to expressive difficult emotions * Week 2: Writing to release \& integrate difficult emotions * Week 3: Writing to nurture gratitude * Week 4: Writing to enhance strengths \& resources * Week 5: Writing to cultivate positive meaning \& savor goodness * Week 6: Writing to invite insight, perspective, \& growth

Sponsors & Collaborators

Principal Investigators

  • Oliver Glass, PhD · Duke University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-26
Primary Completion
2020-08-17
Completion
2020-08-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04589104 on ClinicalTrials.gov